Evidence map›Paper›PMID 40488234›Full record

ArticleMovement disorders clinical practice2025

Informed Consent Procedure for Research Including Patients with Parkinson's Disease and Cognitive Impairment.

Vibuthi Sisodia, Bart E K S Swinnen, Evelien Lemstra, Gert J Geurtsen, Albert F G Leentjens, Martin A J M Buijsen, Maartje H N Schermer, Rob M A de Bie

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Movement disorders clinical practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Vibuthi SisodiaAmsterdam UMC, Amsterdam Neuroscience, University of Amsterdam, Department of Neurology, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0003-2671-9454
Bart E K S SwinnenAmsterdam UMC, Amsterdam Neuroscience, University of Amsterdam, Department of Neurology, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0002-8098-880X
Evelien LemstraAmsterdam UMC, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Department of Neurology, Amsterdam, The Netherlands.
Gert J GeurtsenAmsterdam UMC, Amsterdam Neuroscience, University of Amsterdam, Department of Medical Psychology, Amsterdam, The Netherlands.
Albert F G LeentjensMaastricht University Medical Center, Department of Psychiatry, Maastricht, The Netherlands.ORCID https://orcid.org/0000-0002-7901-571X
Martin A J M BuijsenErasmus School of Law and Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.
Maartje H N SchermerErasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.
Rob M A de BieAmsterdam UMC, Amsterdam Neuroscience, University of Amsterdam, Department of Neurology, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0001-5267-0784

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cognitive impairmentinformed consentParkinson's diseaseParkinson's disease dementia

Identifiers

PMID40488234
PMCPMC12528961

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.